Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr 5:7:285-92.
doi: 10.2147/PPA.S41929. Print 2013.

Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals

Gerhard Klausmann  1 , Irene Hramiak, Marianne Qvist, Kristian Handberg Mikkelsen, Xiaohui Guo
Affiliations

Evaluation of preference for a novel durable insulin pen with memory function among patients with diabetes and health care professionals

Gerhard Klausmann et al. Patient Prefer Adherence. .

Abstract

Background: Improving adherence to insulin treatment for better glycemic control remains a challenge in the management of diabetes. New technological aids are required to help support adherence. This study evaluated preference for the NovoPen(®) 5 (NP5), a durable insulin pen with memory function, compared with the HumaPen Luxura(®) (HPL) among patients with diabetes and health care professionals.

Methods: This crossover, multicenter usability study included insulin pen-experienced patients with diabetes and health care professionals treating patients with diabetes in Canada, China, and Germany. Participants evaluated NP5 and HPL in a randomized order by performing handling tasks in a usability test related to everyday use during a face-to-face interview. Tasks, pens, and preferences were assessed by completing a questionnaire comprised of rating and open-ended questions relating to confidence in everyday diabetes management.

Results: Overall, 300 patients with diabetes and 150 health care professionals participated in the study. Significantly more participants preferred NP5 (81%) to HPL (18%) (P < 0.001). Also, 82% of patients with diabetes had more confidence in NP5 for managing their daily injections versus 11% with HPL (P < 0.001), and 7% had no preference. Memory function was most helpful in giving patients with diabetes confidence about when they last injected (63%), how much insulin they last injected (62%) and improving diabetes management (55%). Participants gave higher ratings to NP5 than to HPL on all parameters relating to performing an injection (ease of handling, satisfaction when using the pen, convenience of using the pen day-to-day, quality of the pen, and the extent to which the pen meets their needs; P < 0.05 for all comparisons).

Conclusion: NP5 was preferred to HPL by most participants. Significantly more patients with diabetes had more confidence for managing daily insulin injections when using NP5, the pen with a memory function.

Keywords: confidence; diabetes; durable insulin pen; memory function; patient preference; usability.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overall confidence of all participants (PwD and HCP) in NP5 compared with HPL for management of daily insulin injections (PwD) or patients’ ability to manage their daily injections (HCP). Note: *P < 0.001 NP5 vs HPL. Abbreviations: HCP, health care professionals; HPL, HumaPen Luxura®; NP5, NovoPen® 5; PwD, patients with diabetes.
Figure 2
Figure 2
Participants’ responses to handling questions relating to NP5 compared with HPL. Note: *P < 0.001 NP5 vs HPL. Abbreviations: HPL, HumaPen Luxura®; NP5, NovoPen® 5.
See this image and copyright information in PMC

References

    1. Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(3):293–301. - PubMed
    1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94(3):311–321. - PubMed
    1. Morrow AS, Haidet P, Skinner J, Naik AD. Integrating diabetes self-management with the health goals of older adults: a qualitative exploration. Patient Educ Couns. 2008;72(3):418–423. - PMC - PubMed
    1. Lernmark A. Type 1 diabetes. Clin Chem. 1999;45(8 Pt 2):1331–1338. - PubMed
    1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352(9131):837–853. [No authors listed] - PubMed